Please login to the form below

Not currently logged in
Email:
Password:

Sarclisa

This page shows the latest Sarclisa news and features for those working in and with pharma, biotech and healthcare.

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi is already involved in this therapy area – in March 2020, the US Food and Drug Administration approved its multiple myeloma treatment Sarclisa (isatuximab). ... The FDA approved Sarclisa for the treatment of patients with relapsed or refractor

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...